Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1971 1
1972 1
1985 1
1986 3
1987 2
1988 2
1989 4
1990 4
1991 2
1995 3
1997 2
1998 1
2004 1
2008 1
2011 1
2012 3
2013 2
2014 2
2015 1
2016 1
2017 2
2018 3
2019 2
2020 4
2021 6
2022 3
2023 6
2024 5
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Patel N, Yancopoulos GD, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Abdulai RM, Robinson LB; NOTUS Study Investigators. Bhatt SP, et al. N Engl J Med. 2024 Jun 27;390(24):2274-2283. doi: 10.1056/NEJMoa2401304. Epub 2024 May 20. N Engl J Med. 2024. PMID: 38767614 Clinical Trial.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Recommendations for the pharmacological treatment of COPD: questions and answers.
Fernandes FLA, Cukier A, Camelier AA, Fritscher CC, Costa CHD, Pereira EDB, Godoy I, Cançado JED, Romaldini JG, Chatkin JM, Jardim JR, Rabahi MF, Nucci MCNM, Sales MDPU, Castellano MVCO, Aidé MA, Teixeira PJZ, Maciel R, Corrêa RA, Stirbulov R, Athanazio RA, Russo R, Minamoto ST, Lundgren FLC. Fernandes FLA, et al. Among authors: minamoto st. J Bras Pneumol. 2017 Jul-Aug;43(4):290-301. doi: 10.1590/S1806-37562017000000153. J Bras Pneumol. 2017. PMID: 29365005 Free PMC article. Review.
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D; Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team. Umehara H, et al. Mod Rheumatol. 2012 Feb;22(1):1-14. doi: 10.1007/s10165-011-0508-6. Epub 2011 Sep 1. Mod Rheumatol. 2012. PMID: 21881964 Free PMC article. Review.
EXTENSOR MECHANISM TRANSPLANTATION AFTER KNEE PROSTHESIS: 70-MONTH FOLLOW-UP.
Helito CP, Mozella AP, Varone BB, Demange MK, Gobbi RG, Minamoto STN, Cobra HAAB. Helito CP, et al. Among authors: minamoto stn. Acta Ortop Bras. 2022 Jul 6;30(spe1):e253424. doi: 10.1590/1413-785220223001e253424. eCollection 2022. Acta Ortop Bras. 2022. PMID: 35864839 Free PMC article.
Proposed diagnostic criteria for IgG4-related respiratory disease.
Matsui S, Yamamoto H, Minamoto S, Waseda Y, Mishima M, Kubo K. Matsui S, et al. Among authors: minamoto s. Respir Investig. 2016 Mar;54(2):130-2. doi: 10.1016/j.resinv.2015.09.002. Epub 2015 Oct 20. Respir Investig. 2016. PMID: 26879484 No abstract available.
66 results